Live from the NIH registry
Studies recruiting near Cary right now
Top 25 of 1,684 recruiting studies, sorted by proximity — each links to its official registry page
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Interstitial Lung Disease
Phase 2
Interventional 445 participants sought
Duke University Medical Center — Durham, North Carolina (15.3 mi)
· Sponsor: Bastiaan Driehuys
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina (16.0 mi)
· Sponsor: American Society of Clinical Oncology
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Duke Cancer Center — Durham, North Carolina (15.3 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Duke University Medical Center — Durham, North Carolina (15.3 mi)
· Sponsor: National Cancer Institute (NCI)
Observation of Environment and Reproductive-Endocrine Effects
Hypogonadism, Hypergonadism
N/A
Observational 300 participants sought
NIEHS Clinical Research Unit (CRU) — Research Triangle Park, North Carolina (8.3 mi)
· Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Nutrition OUtReach In Systems of Healthcare
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Autologous Haemopoietic Stem Cell Transplant
N/A
Interventional 210 participants sought
Duke University — Durham, North Carolina (15.3 mi)
· Sponsor: University of Kansas Medical Center
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
University of North Carolina Medical Center ( Site 0136) — Chapel Hill, North Carolina (16.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
Cleft Palate, Pain
Phase 4
Interventional 60 participants sought
Duke University Medical Center — Durham, North Carolina (15.3 mi)
· Sponsor: Duke University
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
North Carolina Retina Associates — Wake Forest, North Carolina (22.1 mi)
· Sponsor: Boehringer Ingelheim
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
L&E Raleigh — Raleigh, North Carolina (10.2 mi)
· Sponsor: RAI Services Company
Adult and Juvenile Myositis
Dermatomyositis, Polymyositis
N/A
Observational 1,200 participants sought
NIEHS Clinical Research Unit (CRU) — Research Triangle Park, North Carolina (8.3 mi)
· Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
Sarcoidosis
N/A
Observational 27,000 participants sought
Duke University Medical Center — Durham, North Carolina (15.3 mi)
· Sponsor: Duke University
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
UNC- Chapel Hill — Chapel Hill, North Carolina (16.0 mi)
· Sponsor: Guardant Health, Inc.
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Duke Cancer Center — Durham, North Carolina (15.3 mi)
· Sponsor: Nationwide Children's Hospital
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families
Substance Abuse, Intimate Partner Violence (IPV)
N/A
Interventional 400 participants sought
Duke School of Nursing — Durham, North Carolina (15.3 mi)
· Sponsor: Duke University
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Chapel Hill — Chapel Hill, North Carolina (16.0 mi)
· Sponsor: Westat
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
UNC Hospitals Adult Oncology Clinics — Chapel Hill, North Carolina (16.0 mi)
· Sponsor: C4 Therapeutics, Inc.
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Dravet Syndrome
Phase 1, Phase 2
Interventional 32 participants sought
Duke University Health Systems — Durham, North Carolina (15.3 mi)
· Sponsor: Ionis Pharmaceuticals, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UNC Health Cancer Care Cary — Cary, North Carolina (2.3 mi)
· Sponsor: SWOG Cancer Research Network
ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
Abdominal Aortic Aneurysms
N/A
Observational 200 participants sought
UNC - University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (16.0 mi)
· Sponsor: ViTAA Medical Solutions
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Interventional 9 participants sought
Duke University — Durham, North Carolina (15.3 mi)
· Sponsor: Rocket Pharmaceuticals Inc.
Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections
Periprosthetic Joint Infection
Phase 2
Interventional 60 participants sought
Duke University Medical Center — Durham, North Carolina (15.3 mi)
· Sponsor: OsteoRemedies, LLC
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (16.0 mi)
· Sponsor: GentiBio, Inc
Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
Acute Respiratory Failure
N/A
Observational 2,092 participants sought
Duke University School of Medicine — Durham, North Carolina (15.3 mi)
· Sponsor: Brian Driver
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Raleigh, North Carolina (10.2 mi)
· Sponsor: Daiichi Sankyo